David Ortiz was one of the hundred or so ballplayers who tested positive for PEDs during the 2003 survey testing which was designed to determine whether or not baseball’s drug problem was significant enough to warrant full-blown testing the following year. His and everyone else’s name was supposed to remain confidential, but his, Alex Rodriguez and Sammy Sosa’s names were leaked.
At the time his name was leaked, Ortiz said a lot of things about how surprised he was and how he wanted to get to the bottom of it all. Most took this as a deflection and didn’t buy Ortiz’s confusion as genuine. He got busted, most figured, and now he’s acting surprised. How rich.
Well, he’s still surprised about it and is still wondering. From WEEI:
“No. Nobody. Not MLB. Not the Players Association. Nobody,” said Ortiz when asked if anyone had revealed what he had reportedly tested positive for. “They just threw it out there that I tested positive on this one list and that was it. Nothing. So I have to deal with that, and your mind is all over the place. And I’ve lived with it … It is something that is still in the dark because nobody ever had the [guts] to come to me and say, ‘This is what was happening.’ You damaged my image at the time, and it has always stayed like that. No explanation. No nothing.”
Take that for what it’s worth. But ask yourself why Ortiz — along with Andy Pettitte and many others who have had PED associations — don’t get one-tenth the crap thrown on them that Alex Rodriguez does.
And no, this is not a call to throw crap on Ortiz and Pettitte.
According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.
A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.
Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.
Espinosa will reach free agency after the 2017 season.
The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.
The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.
Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.
Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.